Exelixis | DETTE



Debt Changement Date
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Amgen USD 56.2B 1.18B 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Cytokinetics USD 658.13M 1.01M 2025-03
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 39.9B 1.39B 2025-06
Exelixis USD 179.84M 179.84M 2025-06
Genmab DKK 148M 5M 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Pfizer USD 60.93B 1.18B 2025-06
Sanofi 17.91B 5.85B 2024-12
Takeda JPY 4.51T 9.32B 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Xencor USD 67.93M 86.45M 2025-06


Exelixis DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.